News & Views | Published:


Microbiome metabolomics reveals new drivers of human liver steatosis

Nature Medicinevolume 24pages906907 (2018) | Download Citation

An integrative multiomics approach in nondiabetic obese women identifies phenylacetate as a microbial metabolite contributing to the accumulation of lipids in the liver and hence to nonalcoholic steatohepatitis.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Postler, T. S. & Ghosh, S. Cell Metab. 26, 110–130 (2017).

  2. 2.

    Claus, S. P. et al. Mol. Syst. Biol 4, 219 (2008).

  3. 3.

    Delzenne, N. M. & Bindels, L. B. Nat. Rev. Gastroenterol. Hepatol. 15, 69–70 (2017).

  4. 4.

    Hoyles, L. Nat. Med. (2018).

  5. 5.

    Russell, W. R. et al. Mol. Nutr. Food Res. 57, 523–535 (2013).

  6. 6.

    Koppel, N., Maini Rekdal, V. & Balskus, E. P. Science 356, eaag2770 (2017).

Download references

Author information


  1. Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium

    • Nathalie M. Delzenne
    •  & Laure B. Bindels


  1. Search for Nathalie M. Delzenne in:

  2. Search for Laure B. Bindels in:

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to Nathalie M. Delzenne.

About this article

Publication history



Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing